5 clinical trials found.
-
IMPact on Revascularization Outcomes of intraVascular ultrasound guided treatment of complex lesions and Economic impact (IMPROVE)
The study is being done to evaluate the impact of treating complex blockages in the coronary arteries of subjects undergoing percutaneous coronary intervention (PCI) with ...Phase N/A
TRIAL ROLE: Principal Investigator
-
Heart Attack Research Program (HARP)
The Heart Attack Research Program (HARP) is a multi-discipline and mutli-center study that incorporates clinical and basic science and population health to investigate mechanisms of ...Phase N/A TRIAL ROLE: Sub Investigator
-
Impella -Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
The primary objective of the PROTECT IV Trial is to demonstrate the superiority of percutaneous coronary intervention (PCI) performed with Impella mechanical circulatory support (MCS ...Phase N/A TRIAL ROLE: Sub Investigator
-
Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Study
The primary objective of this trial is to test whether FFRangio®-guided treatment is noninferior to conventional pressure wire-guided treatment in patients with coronary artery ...Phase N/A TRIAL ROLE: Sub Investigator
-
A Prospective Multicenter Randomized Two-Arm Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch Sirolimus-Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis (MAGICAL ISR)
The treatment for narrowed or blocked arteries often involves stents, which are inserted into heart blood vessels to alleviate blockages. Drug-eluting stents (DES) release medication ...Phase
TRIAL ROLE: Sub Investigator
